Pre-existing osteoporosis and serum vitamin D levels in patients with distal radius fractures: are we missing something?

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a clinical trial.

The analysis will also consider patients' serum vitamin D levels and the indications for basic osteoporosis diagnostic tests and osteoporosis therapy prior to fracture.

Who Took Part

The age groups tagged for this paper are middle-aged adults, older adults and people over 80.

This prospective clinical trial included patients with distal radius fractures who underwent surgery at their hospital between 1 April 2021 and 7 April 2022.

Blood samples were taken from all participants and existing risk factors for osteoporosis were recorded.

How the Study Was Run

In addition, the indication for a guideline-based osteoporosis diagnosis was assessed and the risk of another future fracture with FRAX® was calculated.

This information was used to decide whether there was an indication for specific osteoporosis therapy.

What Was Measured

The analysis will also consider patients' serum vitamin D levels and the indications for basic osteoporosis diagnostic tests and osteoporosis therapy prior to fracture.

PubMed files the paper under topics including Bone Density, Osteoporosis, Osteoporotic Fractures, Radius Fractures, Risk Factors, Vitamin D and Wrist Fractures.

Author keywords: Diagnosis gap, Distal radius, Elderly and Treatment gap.

What This Means in Plain Language

This is a clinical trial of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2024 (Archives of orthopaedic and trauma surgery), a journal based in Germany.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.